Genus Plc Stock Working Capital
| GENSF Stock | USD 21.01 0.11 0.53% |
Genus plc fundamentals help investors to digest information that contributes to Genus Plc's financial success or failures. It also enables traders to predict the movement of Genus Pink Sheet. The fundamental analysis module provides a way to measure Genus Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genus Plc pink sheet.
Genus |
Genus plc Company Working Capital Analysis
Genus Plc's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Genus Plc Working Capital | 138.7 M |
Most of Genus Plc's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genus plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
According to the company's disclosures, Genus plc has a Working Capital of 138.7 M. This is 67.41% lower than that of the Healthcare sector and 74.25% lower than that of the Biotechnology industry. The working capital for all United States stocks is 90.62% higher than that of the company.
Genus Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genus Plc's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Genus Plc could also be used in its relative valuation, which is a method of valuing Genus Plc by comparing valuation metrics of similar companies.Genus Plc is currently under evaluation in working capital category among its peers.
Genus Fundamentals
| Return On Equity | 0.0687 | |||
| Return On Asset | 0.0379 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 2.62 B | |||
| Shares Outstanding | 65.77 M | |||
| Shares Owned By Insiders | 0.66 % | |||
| Shares Owned By Institutions | 71.65 % | |||
| Price To Earning | 34.61 X | |||
| Price To Book | 3.47 X | |||
| Price To Sales | 4.15 X | |||
| Revenue | 593.4 M | |||
| Gross Profit | 226 M | |||
| EBITDA | 93.1 M | |||
| Net Income | 40.9 M | |||
| Cash And Equivalents | 38.8 M | |||
| Cash Per Share | 0.59 X | |||
| Total Debt | 182.1 M | |||
| Debt To Equity | 0.39 % | |||
| Current Ratio | 1.70 X | |||
| Book Value Per Share | 8.85 X | |||
| Cash Flow From Operations | 34.3 M | |||
| Earnings Per Share | 0.75 X | |||
| Number Of Employees | 3.5 K | |||
| Beta | 0.46 | |||
| Market Capitalization | 2.27 B | |||
| Total Asset | 1.02 B | |||
| Retained Earnings | (119.78 M) | |||
| Working Capital | 138.7 M | |||
| Current Asset | 216.1 M | |||
| Current Liabilities | 77.4 M | |||
| Z Score | 7.2 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 1.02 B | |||
| Last Dividend Paid | 0.32 |
About Genus Plc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Genus plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genus Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genus plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Genus Pink Sheet
Genus Plc financial ratios help investors to determine whether Genus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genus with respect to the benefits of owning Genus Plc security.